(a) The consensus trajectory of tumor-associated CD8+ T cells in non-small cell lung cancer (NSCLC) identified CD8-ZNF683-T1 and CD8-ZNF683-T2 as two subtypes of CD8-ZNF683, which are influenced by TBX21. Here, TBX21 is linked to non-small cell lung carcinoma.